特一藥業(002728.SZ)與東莞國藥就“止咳寶片、皮膚病血毒丸”等產品及“特一系列產品”達成戰略合作意向
格隆匯 8 月 6日丨特一藥業(002728.SZ)公佈,為了更好地服務終端顧客,強化品牌影響力,加強與區域連鎖藥店的直接聯繫,完善營銷渠道。公司與廣東省東莞國藥集團有限公司(“東莞國藥”)於2020年8月5日在台山市簽訂了《戰略合作協議》。
特一藥業與東莞國藥就“止咳寶片、皮膚病血毒丸”等經典名方產品及“特一系列產品”達成戰略合作意向,以患者為中心,投入更多的動銷資源,推動雙方戰略合作業務不斷深入發展。
近年來,公司針對醫藥市場和渠道展現出多元化的趨勢,在現有業務的基礎上,公司加強直接與全國百強連鎖和區域重點連鎖的銷售業務比重,加強與這些連鎖藥店的管理和業務聯繫,做到營銷渠道的多元化,提高市場覆蓋的深度、廣度,提高產品市場佔有率。此次戰略合作,有利於雙方發揮各自資源優勢,提升終端服務及強化品牌影響力,實現優勢互補、互利互贏,符合公司的發展戰略佈局。若後續合作順利實施,將對公司未來的業務開拓及經營業績產生積極的影響,符合公司股東的長遠利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.